Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - Avalon Globocare ( NASDAQ:ALBT )

  2 weeks ago   
post image
FREEHOLD, N.J., Oct. 31, 2024 ( GLOBE NEWSWIRE ) -- Avalon GloboCare Corp. ( "Avalon" or the "Company" ) ALBT, a developer of innovative precision diagnostics and laboratory services, today announced that it has appointed Dr. Charles Cavo to its Scientific and Clinical Advisory Board.
Ticker Sentiment Impact
ALBT
Somewhat Bullish
28 %